Skip to main content
Signal8

Atlas Venture Life Science Advisors, LLC

Atlas Venture Life Science Advisors, LLC is an Investment Adviser institutional filer with the SEC under CIK 1917529, reporting 7 portfolio positions, with 20 historical 13F filings on file. Most recent reporting period: 2026-06-30.

A Form 13F reports a manager's US-listed stock and option positions only. It does not include real estate, private funds, bonds, cash or non-US holdings, so a 13F portfolio value is not the firm's total assets under management (AUM).

  • State of incorporation: DE
  • Filing type: 13F-HR
  • Latest reporting period: 2026-06-30
  • Last filed: 2026-08-13

Top 7 portfolio positions

The largest reported holdings in Atlas Venture Life Science Advisors, LLC's most recent 13F filing, ranked by reported market value.

  1. Kymera Therapeutics, Inc. (KYMR)
  2. Dyne Therapeutics, Inc. (DYN)
  3. Sionna Therapeutics, Inc. (SION)
  4. Kailera Therapeutics, Inc. (KLRA)
  5. Disc Medicine, Inc. (IRON)
  6. Q32 Bio, Inc. (QTTB)
  7. Korro Bio, Inc. (KRRO)
/